ScholarIQanswers from OpenAlex & ORCID
Arlene Chan
ResearcherPublications, citations & collaboration network
Arlene Chan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Arlene Chan have?
ScholarIQindexed works
Arlene Chan has 281 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Arlene Chan have?
ScholarIQcitation count
Arlene Chan has 19,067 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Arlene Chan?
ScholarIQh-index
Arlene Chan has an h-index of 42 in OpenAlex.
What is the i10-index of Arlene Chan?
ScholarIQi10-index
Arlene Chan has an i10-index of 107 in OpenAlex.
What is the ORCID of Arlene Chan?
ScholarIQorcid
The ORCID for Arlene Chan is on the source record.
What is the OpenAlex record for Arlene Chan?
ScholarIQopenalex
The OpenAlex for Arlene Chan is on the source record.
What are the most-cited papers on Arlene Chan?
ScholarIQmost cited works
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press, John R. Mackey, John A. Glaspy, Arlene Chan, Marek Pawlicki, Tamás Pintér, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gϋnter von Minckwitz, F. Visco, Valerie Bée, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, A. Riva, John Crown
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Gabriel N. Hortobágyi, Salomon M. Stemmer, Howard A. Burris, Yoon Sim Yap, Gabe S. Sonke, Shani Paluch–Shimon, Mario Campone, Kimberly Blackwell, Fabrice André, Eric P. Winer, Wolfgang Janni, Sunil Verma, PierFranco Conte, Carlos L. Arteaga, David Cameron, Katarína Petráková, Lowell L. Hart, Cristian Villanueva, Arlene Chan, Erik Jakobsen, Arnd Nusch, Olga Burdaeva, Eva‐Maria Grischke, Emilio Alba, Erik Wist, Norbert Marschner, Anne Favret, Denise A. Yardley, Thomas Bachelot, Ling-Ming Tseng, Sibel Blau, Fengjuan Xuan, Farida Souami, Michelle C. Miller, Caroline Germa, Samit Hirawat, Joyce O’Shaughnessy
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy, Hiroji Iwata, Gϋnter von Minckwitz, Stephen Chia, Janine Mansi, Carlos H. Barrios, Michael Gnant, Z. Tomasevic, Neelima Denduluri, Robert Šeparović, Erhan Gökmen, Anna Bashford, Manuel Ruíz Borrego, Sung‐Bae Kim, Erik Jakobsen, A. Ciceniene, Kenichi Inoue, Friedrich Overkamp, Joan B. Heijns, Anne Armstrong, John S. Link, Anil A. Joy, Richard Bryce, Alvin Wong, Susan Moran, Bin Yao, Feng Xu, Alan Auerbach, Marc Buyse, Arlene Chan, Vernon Harvey, Rudolf Tomek, Nicholas J. Robert, Ira Gore, John W. Smith, Norikazu Masuda, S. Di Sean Kendall, William Graydon Harker, Katarína Petráková, Ángel Guerrero‐Zotano, Amparo Ruiz Simón, Zora Neskovic Konstantinovic, Nicholas Iannotti, Pierfrancesco Tassone, Gladys Rodriguez, Noelia Jáñez Martínez, Carmen Crespo Massieu, Snezana Smickoska, Işıl Somali, Uğur Yılmaz, Mirta Garcia Alonso, Adolfo Rosales, Soeren Cold, Ann Knoop, Debra A. Patt, Beth A. Hellerstedt, Serafin Morales Murillo, Ingrid A. Mayer, Julie A. Means‐Powell, Rina Hui, Francis M. Senecal, Richard Hendry De Boer, Zhenzhou Shen, A.A. Luczak, Joanna W.Y. Chui, Janice Tsang, István Láng, Yoshiaki Rai, Yasuo Hozumi, Albert J. ten Tije, Manish Bhandari, Cynthia R. Osborne, Shoichiro Ohtani, Kenji Higaki, Kenichi Watanabe, Kazunori TAGUCHI, Masato Takahashi, Sladjana Filipovic, Vincent Hansen, Vijayarama Phooshkooru Rao, Manish Gupta, Petar Petrov, Bruno Coudert, Željko Vojnović, Zsofia Polya, Toshiko Miyaki, Naohito Yamamoto, Stephen Brincat, Krzysztof Leśniewski-Kmak, Ewa Chmielowska, Ruemu Birhiray, Marc L. Citron, Steven W. Papish, William L. Berry, Sven Tyge Langkjer, José Á. García-Sáenz
Challenges to effective cancer control in China, India, and Russia
Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky, Lei Fan, Junjie Li, Yanin Chávarri-Guerra, Pedro Emanuel Rubini Liedke, C.S. Pramesh, Tanja Badovinac-Črnjević, Yuri Sheikine, Chen Zhu, You‐Lin Qiao, Zhi‐Ming Shao, Yi‐Long Wu, Daiming Fan, Louis W.C. Chow, Jun Wang, Qiong Zhang, Shiying Yu, Gordon C Shen, Jie He, Arnie Purushotham, Richard Sullivan, Rajendra Badwe, Shripad Banavali, Reena Nair, Lalit Kumar, Purvish M. Parikh, Somasundarum Subramanian, Pankaj Chaturvedi, Subramania Iyer, Surendra S. Shastri, Raghunadharao Digumarti, Enrique Soto‐Pérez‐de‐Celis, Dauren Adilbay, Semiglazov Vf, С. В. Орлов, Dilyara Kaidarova, Ilya Tsimafeyeu, Sergei Tatishchev, Kirill D Danishevskiy, Marc Hurlbert, Caroline Vail, Jessica St. Louis, Arlene Chan
Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Antonio C. Wolff, Ann Lazar, Igor Bondarenko, August Garin, Stephen Brincat, Louis W.C. Chow, Yan Sun, Zora Nešković‐Konstantinović, Rodrigo C. Guimarães, P. Fumoleau, Arlene Chan, Soulef Hachemi, Andrew Strahs, Maria Cincotta, Anna Berkenblit, Mizue Krygowski, Lih Lisa Kang, Laurence Moore, Daniel F. Hayes